Sobrevida de pacientes con cáncer de esófago sometidos a esofagectomía total torácica

Background: Esophageal carcinoma has a dismal prognosis. Several authors have reported a very low survival in Chile. Aim: To report the survival of patients with esophageal carcinoma, subjected to esophageal resection. Material and methods: Analysis of 108 patients subjected to thoracic esophageal r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Braghetto M,talo, Csendes J,Attila, Cornejo O,Aquiles, Amat V,José, Cardemil H,Gonzalo, Burdiles P,Patricio, Korn B,Owen
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2000
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872000000100009
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872000000100009
record_format dspace
spelling oai:scielo:S0034-988720000001000092000-05-25Sobrevida de pacientes con cáncer de esófago sometidos a esofagectomía total torácicaBraghetto M,taloCsendes J,AttilaCornejo O,AquilesAmat V,JoséCardemil H,GonzaloBurdiles P,PatricioKorn B,Owen Esophageal neoplasms Neoplasm staging Surgery, operative Background: Esophageal carcinoma has a dismal prognosis. Several authors have reported a very low survival in Chile. Aim: To report the survival of patients with esophageal carcinoma, subjected to esophageal resection. Material and methods: Analysis of 108 patients subjected to thoracic esophageal resection between 1985 and 1996. Patients were classified according to the location of the tumor and its staging. Results: Eleven patients died in the immediate postoperative period and 90 patients were followed. In 53 the exact cause of death was determined. Global five years survival was 29% and median survival was 18 months. Survival was 100% in stage I tumors. Adjuvant therapy resulted in a better survival of stage III tumors. Survival of stage IV tumors was worst than stage I to III tumors. There was no survival difference between squamous carcinoma or adenocarcinoma. Tumors located in the superior third of the esophagus had a worst prognosis. Causes of death were mediastinic metastases, local recidivism, pleural or pulmonary metastases and less frequently, brain, bronchial or bone metastases. Conclusions: The survival of these, patients with esophageal carcinoma did not differ from the figures reported abroad. (Rev Méd Chile 2000; 128: 64-74)info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.128 n.1 20002000-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872000000100009es10.4067/S0034-98872000000100009
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Esophageal neoplasms
Neoplasm staging
Surgery, operative
spellingShingle Esophageal neoplasms
Neoplasm staging
Surgery, operative
Braghetto M,talo
Csendes J,Attila
Cornejo O,Aquiles
Amat V,José
Cardemil H,Gonzalo
Burdiles P,Patricio
Korn B,Owen
Sobrevida de pacientes con cáncer de esófago sometidos a esofagectomía total torácica
description Background: Esophageal carcinoma has a dismal prognosis. Several authors have reported a very low survival in Chile. Aim: To report the survival of patients with esophageal carcinoma, subjected to esophageal resection. Material and methods: Analysis of 108 patients subjected to thoracic esophageal resection between 1985 and 1996. Patients were classified according to the location of the tumor and its staging. Results: Eleven patients died in the immediate postoperative period and 90 patients were followed. In 53 the exact cause of death was determined. Global five years survival was 29% and median survival was 18 months. Survival was 100% in stage I tumors. Adjuvant therapy resulted in a better survival of stage III tumors. Survival of stage IV tumors was worst than stage I to III tumors. There was no survival difference between squamous carcinoma or adenocarcinoma. Tumors located in the superior third of the esophagus had a worst prognosis. Causes of death were mediastinic metastases, local recidivism, pleural or pulmonary metastases and less frequently, brain, bronchial or bone metastases. Conclusions: The survival of these, patients with esophageal carcinoma did not differ from the figures reported abroad. (Rev Méd Chile 2000; 128: 64-74)
author Braghetto M,talo
Csendes J,Attila
Cornejo O,Aquiles
Amat V,José
Cardemil H,Gonzalo
Burdiles P,Patricio
Korn B,Owen
author_facet Braghetto M,talo
Csendes J,Attila
Cornejo O,Aquiles
Amat V,José
Cardemil H,Gonzalo
Burdiles P,Patricio
Korn B,Owen
author_sort Braghetto M,talo
title Sobrevida de pacientes con cáncer de esófago sometidos a esofagectomía total torácica
title_short Sobrevida de pacientes con cáncer de esófago sometidos a esofagectomía total torácica
title_full Sobrevida de pacientes con cáncer de esófago sometidos a esofagectomía total torácica
title_fullStr Sobrevida de pacientes con cáncer de esófago sometidos a esofagectomía total torácica
title_full_unstemmed Sobrevida de pacientes con cáncer de esófago sometidos a esofagectomía total torácica
title_sort sobrevida de pacientes con cáncer de esófago sometidos a esofagectomía total torácica
publisher Sociedad Médica de Santiago
publishDate 2000
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872000000100009
work_keys_str_mv AT braghettomtalo sobrevidadepacientesconcancerdeesofagosometidosaesofagectomiatotaltoracica
AT csendesjattila sobrevidadepacientesconcancerdeesofagosometidosaesofagectomiatotaltoracica
AT cornejooaquiles sobrevidadepacientesconcancerdeesofagosometidosaesofagectomiatotaltoracica
AT amatvjose sobrevidadepacientesconcancerdeesofagosometidosaesofagectomiatotaltoracica
AT cardemilhgonzalo sobrevidadepacientesconcancerdeesofagosometidosaesofagectomiatotaltoracica
AT burdilesppatricio sobrevidadepacientesconcancerdeesofagosometidosaesofagectomiatotaltoracica
AT kornbowen sobrevidadepacientesconcancerdeesofagosometidosaesofagectomiatotaltoracica
_version_ 1718435899895709696